AI
LJPC

Axiom Investors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Axiom Investors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-41,310
Closed -$1.23M – 170
2018
Q1 		$1.23M Sell
41,310
-22,585
-35% -$728K 0.03% 139
2017
Q4 		$2.06M Buy
63,895
+7,524
+13% +$246K 0.05% 120
2017
Q3 		$1.96M Buy
56,371
+1,062
+2% +$34.2K 0.04% 120
2017
Q2 		$1.65M Buy
55,309
+2,119
+4% +$60.7K 0.04% 127
2017
Q1 		$1.59M Buy
+53,190
New +$1.36M 0.04% 135

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Axiom Investors's LJPC Position: Q2 2018 in Review

Axiom Investors sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 41,310 shares — an estimated $1.23M sold.

Axiom Investors first reported a position in LJPC in Q1 2017 and held it in 5 quarters. The position peaked at $2.06M in Q4 2017. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

  • Axiom Investors reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
  • Axiom Investors sold 41,310 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $1.23M.
  • Axiom Investors first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 5 quarters.
  • Axiom Investors's La Jolla Pharmaceutical Company position peaked at $2.06M in Q4 2017.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on Axiom Investors's 13F filing for Q2 2018, filed 13 Aug 2018.